No Data
No Data
Nirvana Life Sciences Inc To Carry Out 1-for-10 Reverse Stock Split On March 24th, 2025
CSE Bulletin: Reinstatement - Nirvana Life Sciences Inc. (NIRV)
Nirvana Raises $24.2M Series A to Revolutionize Health Insurance Verification
Xai Foundation Launches Nodes on Nirvana Cloud, Ushering In a New Era of Layer 3 Scalability and Cutting Edge Web3 Cloud Computing for Gaming
Nirvana Life Sciences Inc. Announces Receipt of First North American Production of SOSA, a Patented, WHO Approved, Herbal Treatment for Opiate Addiction
Nirvana Life Sciences Inc: INTERIM MDA EN